top of page

Zelboraf Tablet 240mg

Product details

Registration number: SIN14308P

Classification: Prescription Only

Active ingredients: Vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib

Strength: 240mg

Dosage form: TABLET, FILM COATED

Route: ORAL

Registrant: ROCHE SINGAPORE PTE. LTD.

ATC code: L01XE15

HSA approval date: 4 February 2013

Manufacturer(s): Delpharm Milano S.r.l.

Manufacturing country/countries: ITALY

What are the HSA registration number and classification for Zelboraf Tablet 240mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14308P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Zelboraf Tablet 240mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Vemurafenib in hypromellose acetate succinate 800mg eqv to vemurafenib

Strength: 240mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Zelboraf Tablet 240mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, FILM COATED

Route: ORAL

Source for this answer

Who is the recorded registrant for Zelboraf Tablet 240mg?

According to the HSA dataset updated 7 August 2026:

Registrant: ROCHE SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Zelboraf Tablet 240mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Delpharm Milano S.r.l.

Manufacturing country/countries: ITALY

Source for this answer

Where can I look up Zelboraf Tablet 240mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14308P or the exact product name Zelboraf Tablet 240mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Zelboraf Tablet 240mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Zelboraf Tablet 240mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14308P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page